American Money Management’s Teva Pharmaceuticals TEVA Stock Holding History

American Money Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-2,930	Closed	-$173K	–	82
2015 Q2	$173K	Sell	2,930 -36,117	-92%	-$2.23M	0.15%	84
2015 Q1	$2.43M	Sell	39,047 -1,415	-3%	-$82.3K	2.13%	13
2014 Q4	$2.33M	Sell	40,462 -1,009	-2%	-$56.2K	2.01%	12
2014 Q3	$2.23M	Sell	41,471 -7,852	-16%	-$416K	1.89%	13
2014 Q2	$2.59M	Sell	49,323 -1,700	-3%	-$86.9K	2.12%	10
2014 Q1	$2.7M	Sell	51,023 -715	-1%	-$33K	2.29%	10
2013 Q4	$2.07M	Buy	+51,738	New	+$2.04M	1.79%	14

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

American Money Management's TEVA Position: Q3 2015 in Review

American Money Management sold out of Teva Pharmaceuticals (TEVA) in Q3 2015, closing a stake of 2,930 shares — an estimated $173K sold.

American Money Management first reported a position in TEVA in Q4 2013 and held it in 7 quarters. The position peaked at $2.7M in Q1 2014. 824 funds tracked by Wall St. Rank hold TEVA as of Q3 2015.

American Money Management reported no remaining Teva Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
American Money Management sold 2,930 Teva Pharmaceuticals shares in Q3 2015, an estimated $173K.
American Money Management first reported a position in Teva Pharmaceuticals in Q4 2013 and held it in 7 quarters.
American Money Management's Teva Pharmaceuticals position peaked at $2.7M in Q1 2014.
824 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2015.

Based on American Money Management's 13F filing for Q3 2015, filed 12 Nov 2015.